Epcoritamab combined with R-CHOP significantly improved progression free survival in patients with newly diagnosed DLBCL across both the primary endpoint and total populations.

Quarterly nursing quality summits are evaluated as a strategy to enhance leadership accountability, drive zero harm, and ...

Researchers evaluated the optimal duration of neoadjuvant radiotherapy for patients with locally advanced rectal cancer.

Urine cell-free (cf)RNA analysis could represent a promising biomarker for bladder cancer, according to a study published online Oct. 2 in Nature Medicine. Kevin J. Liu, PhD, from Stanford University ...

A systematic review and meta-analysis evaluated qualitative evidence on the experiences of MBC survivors to understand how they cope with associated challenges.

A cross-sectional study evaluated oncology nurses' readiness, knowledge, and confidence in incorporating genomics into practice to identify educational needs for cancer care.

SM-AML can remain occult until cytoreduction shows MC proliferation, highlighting a potential role for SM evaluation in KIT-positive AML.

Supported by phase 3 OASIS-4 data, elinzanetant significantly reduced daily hot flash frequency in women receiving endocrine therapy for HR-positive breast cancer.

A chemotherapy-free, response-adapted regimen of frontline mosunetuzumab achieved high complete response rates and durable remission in patients with untreated FL or MZL.

A longitudinal study assessed cognitive trajectories in older and younger adults receiving CAR T-cell therapy for large B-cell lymphoma.

A global study reveals that second-hand smoke exposure caused 1.66 million deaths in 2023, highlighting persistent risks for women and children.

Cancer survivors are less likely to be physically active than adults without a cancer history, although physical activity (PA) increased in cancer survivors from 2018 to 2024, according to a study ...